MetaADEDB 2.0 @ LMMD
benserazide, levodopa drug combination
(QFLMOYQNYBDXMT-ZCMDIHMWSA-N)
Structure
SMILES
OC(=O)[C@H](Cc1ccc(c(c1)O)O)N.OCC(C(=O)NNCc1ccc(c(c1O)O)O)N
Molecular Formula:
C19H26N4O9
Molecular Weight:
454.431
Log P:
0.4784
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
11
TPSA:
251.85
CAS Number(s):
37270-69-2
Synonym(s)
1.
benserazide, levodopa drug combination
2.
Ro 8-0576
3.
Ro 8-0576-12
4.
Ro 8-0576-7
5.
benserazide - levodopa
6.
madopa
7.
madopar
8.
modopar
External Link(s)
MeSHC005177
PubChem Compound123809
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Catalepsy7957769
8177909
CTD
2Chorea6842240
14757136
CTD
3Confusion2046949CTD
4Dyskinesia, Drug-Induced

View details

CTD
5Dystonia

View details

CTD
6Fever2046949CTD
7Gliosis31381935CTD
8Hallucinations2046949
12815666
CTD
9Hypokinesia742858
28185818
31381935
CTD
10Meige Syndrome6842240CTD
11Motor Skills Disorders19196941CTD
12Movement Disorders

View details

CTD
13Muscle Rigidity2046949CTD
14Muscle Weakness28185818
31381935
CTD
15Mutism2046949CTD
16Myoclonus7439114CTD
17Neurobehavioral Manifestations28185818CTD
18Parkinson Disease

View details

CTD
19Parkinsonian Disorders

View details

CTD
20Psychoses, Substance-Induced20966038CTD
21Restless Legs Syndrome17230484CTD
22Schizophrenia706CTD
23Seizures8471829CTD
24Sleep Wake Disorders11437169CTD
25Substance Withdrawal Syndrome15314141CTD
26Tremor12588639CTD
27Wallerian Degeneration31381935CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.